---
title: "12 Health Care Stocks Moving In Wednesday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292099384.md"
description: "During Wednesday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Catheter Precision (VTAK) up 95.7%, Tvardi Therapeutics (TVRD) up 50.64%, and Elicio Therapeutics (ELTX) up 24.46%. Conversely, losers featured Chemomab Therapeutics (CMMB) down 31.1%, BioXcel Therapeutics (BTAI) down 20.92%, and Cuprina Holdings (CUPR) down 19.69%. The report highlights specific price movements and market capitalizations for these listed entities."
datetime: "2026-07-08T17:05:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292099384.md)
  - [en](https://longbridge.com/en/news/292099384.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292099384.md)
---

# 12 Health Care Stocks Moving In Wednesday's Intraday Session

### Gainers

-   **Catheter Precision** (AMEX:VTAK) shares moved upwards by 95.7% to $1.4 during Wednesday's regular session. The market value of their outstanding shares is at $2.5 million.
-   **Tvardi Therapeutics** (NASDAQ:TVRD) shares moved upwards by 50.64% to $4.67. The market value of their outstanding shares is at $29.0 million.
-   **Elicio Therapeutics** (NASDAQ:ELTX) stock increased by 24.46% to $3.48. The company's market cap stands at $53.4 million.
-   **Stablecoin Development** (AMEX:SDEV) stock rose 17.59% to $1.47. The market value of their outstanding shares is at $33.8 million.
-   **Regencell Bioscience** (NASDAQ:RGC) shares increased by 17.47% to $6.99. The market value of their outstanding shares is at $2.9 billion.
-   **Innovative Eyewear** (NASDAQ:LUCY) stock moved upwards by 14.56% to $1.46. The company's market cap stands at $8.1 million.

### Losers

-   **Chemomab Therapeutics** (NASDAQ:CMMB) shares declined by 31.1% to $1.91 during Wednesday's regular session. The company's market cap stands at $19.9 million.
-   **BioXcel Therapeutics** (NASDAQ:BTAI) shares fell 20.92% to $0.82. The company's market cap stands at $32.1 million.
-   **Cuprina Holdings (Cayman)** (NASDAQ:CUPR) stock fell 19.69% to $4.61. The market value of their outstanding shares is at $15.3 million.
-   **electroCore** (NASDAQ:ECOR) shares decreased by 14.92% to $6.73. The company's market cap stands at $65.6 million.
-   **Bone Biologics** (NASDAQ:BBLG) shares decreased by 14.29% to $1.26. The market value of their outstanding shares is at $2.6 million.
-   **Lantern Pharma** (NASDAQ:LTRN) stock decreased by 13.03% to $3.1. The market value of their outstanding shares is at $45.5 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [CUPR.US](https://longbridge.com/en/quote/CUPR.US.md)
- [TVRD.US](https://longbridge.com/en/quote/TVRD.US.md)
- [ELTX.US](https://longbridge.com/en/quote/ELTX.US.md)
- [BTAI.US](https://longbridge.com/en/quote/BTAI.US.md)
- [VTAK.US](https://longbridge.com/en/quote/VTAK.US.md)
- [CMMB.US](https://longbridge.com/en/quote/CMMB.US.md)
- [SDEV.US](https://longbridge.com/en/quote/SDEV.US.md)
- [RGC.US](https://longbridge.com/en/quote/RGC.US.md)
- [LUCY.US](https://longbridge.com/en/quote/LUCY.US.md)
- [ECOR.US](https://longbridge.com/en/quote/ECOR.US.md)
- [BBLG.US](https://longbridge.com/en/quote/BBLG.US.md)
- [LTRN.US](https://longbridge.com/en/quote/LTRN.US.md)
- [LUCYW.US](https://longbridge.com/en/quote/LUCYW.US.md)
- [BBLGW.US](https://longbridge.com/en/quote/BBLGW.US.md)

## Related News & Research

- [Tvardi Therapeutics plans 2027 mid-to-late stage ulcerative colitis trial for STAT3 inhibitor TTI-109](https://longbridge.com/en/news/294357121.md)
- [BioXcel Therapeutics Amends Credit Agreement, Tightens Liquidity](https://longbridge.com/en/news/291789314.md)
- [Flyte Partners with LDV at The Maidstone to Elevate Luxury Travel to the Hamptons | VTAK Stock News](https://longbridge.com/en/news/294216437.md)
- [Voyager Therapeutics (VYGR) to Announce Quarterly Earnings on Wednesday](https://longbridge.com/en/news/294203494.md)
- [Bollard Group LLC Reduces Position in Aclaris Therapeutics, Inc. $ACRS](https://longbridge.com/en/news/293815783.md)